Literature DB >> 11732852

Genetic analysis of mosaicism in 53 women with Turner syndrome.

L Hanson1, I Bryman, M L Barrenäs, P O Janson, J Wahlström, K Albertsson-Wikland, C Hanson.   

Abstract

Mosaicism involving the sex chromosomes is a common finding in women with Turner syndrome (TS). It is especially important to detect Y-chromosomal material, since this is a risk factor for the development of gonadoblastoma. Recent studies have also indicated that the frequency of 45,X cells may be used to predict prognosis. As part of an ongoing multi-disciplinary study, we have examined the extent of Y-chromosomal material and sex chromosomal mosaicism and its tissue specificity in 53 women with TS. The results of lymphocyte karyotyping were compared with the use of interphase X/Y fluorescence in situ hybridisation (FISH) analysis of lymphocytes and buccal mucosal cells. As could be expected, an extended FISH analysis detected more Y-chromosomal material than karyotyping (in 15% vs. 11% of the women, respectively) and also detected more X-chromosomal mosaicism among the TS women (in 70% vs. 45 % of the women, respectively). In half of the women, tissue-specific differences between lymphocytes and buccal mucosal cells were found. Based on these results, we suggest the use of X/Y interphase FISH as a complement to karyotyping in order to obtain a more complete knowledge of the chromosome constitution of each individual with TS.

Entities:  

Mesh:

Year:  2001        PMID: 11732852     DOI: 10.1111/j.1601-5223.2001.00153.x

Source DB:  PubMed          Journal:  Hereditas        ISSN: 0018-0661            Impact factor:   3.271


  9 in total

1.  The proportion of diploid 46,XX cells increases with time in women with Turner syndrome--a 10-year follow-up study.

Authors:  Anna-Maria Denes; Kerstin Landin-Wilhelmsen; Yvonne Wettergren; Inger Bryman; Charles Hanson
Journal:  Genet Test Mol Biomarkers       Date:  2015-01-14

2.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681

3.  Upper limb hemimelia in a twin pregnancy which was obtained by an ICSI and PGD in a woman with mosaic Turner's syndrome and the prognosis.

Authors:  Ahter Tanay Tayyar; Ahmet Tayyar; Ahmet Eser; Çetin Kılıçcı; İlter Yenidede; Selçuk Selçuk
Journal:  Organogenesis       Date:  2017-09-21       Impact factor: 2.500

4.  Spontaneous pregnancies in a Turner syndrome woman with Y-chromosome mosaicism.

Authors:  Kerstin Landin-Wilhelmsen; Inger Bryman; Charles Hanson; Lars Hanson
Journal:  J Assist Reprod Genet       Date:  2004-06       Impact factor: 3.412

5.  Cytogenetics of premature ovarian failure: an investigation on 269 affected women.

Authors:  Simona Baronchelli; Donatella Conconi; Elena Panzeri; Angela Bentivegna; Serena Redaelli; Sara Lissoni; Fabiana Saccheri; Nicoletta Villa; Francesca Crosti; Elena Sala; Emanuela Martinoli; Marinella Volontè; Anna Marozzi; Leda Dalprà
Journal:  J Biomed Biotechnol       Date:  2011-01-17

Review 6.  The Hypothesis of the Prolonged Cell Cycle in Turner Syndrome.

Authors:  Francisco Álvarez-Nava; Marisol Soto-Quintana
Journal:  J Dev Biol       Date:  2022-05-11

7.  Turner syndrome and the evolution of human sexual dimorphism.

Authors:  Bernard Crespi
Journal:  Evol Appl       Date:  2008-02-22       Impact factor: 5.183

8.  Reproductive and obstetric outcomes in mosaic Turner's Syndrome: a cross-sectional study and review of the literature.

Authors:  Emek Doğer; Yiğit Çakıroğlu; Yasin Ceylan; Esen Ulak; Özkan Özdamar; Eray Çalışkan
Journal:  Reprod Biol Endocrinol       Date:  2015-06-10       Impact factor: 5.211

9.  Side differences in the degree of mosaicism of the buccal mucosa in Turner syndrome.

Authors:  Sofia Thunström; Kerstin Landin-Wilhelmsen; Inger Bryman; Charles Hanson
Journal:  Mol Genet Genomic Med       Date:  2019-08-29       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.